BioWorld

BLR Bio’s BLR-200 shows promise in systemic sclerosis models

BLR Bio LLC has presented new data highlighting the potential of BLR-200 for the treatment of systemic sclerosis (scleroderma). The company also presented data on its research on CCN proteins as ...
ascopubs.org

Machine learning model to predict mortality after discharge in hospitalized oncologic patients (pts) under active systemic therapy in the advanced setting: A multicenter cross ...

Impact of cisplatin-induced hearing loss (CIHL) on patient-reported social and emotional functioning. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not ...
ascopubs.org

Prognostic Significance of the BALAD Serological Model in Systemic Therapies for Hepatocellular Carcinoma: A Personalized Approach to the Prediction of Survival Benefit

The BALAD score had good prognostic ability for predicting OS and PFS in patients with advanced uHCC who underwent systemic therapies and was associated with treatment response. Application of the ...
The American Journal of Managed Care

Oncology Care Model Tied to Reduced Chemotherapy, Lower Medicare Spending in Poor-Prognosis Cancers

The CMS Oncology Care Model (OCM) was associated with reduced chemotherapy initiation and lower Medicare spending among ...